Delivery Order SPE2DE21D0005-SPE2D625F8FT8
Award Date 7/23/25
Potential Completion Date 7/28/25
Potential Value $8.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,274.00 to Organogenesis Inc. for the supply of PURAPLY Micronized 500mg, an advanced wound care product. The contract, awarded on July 23, 2025, with an ultimate completion date of July 28, 2025, utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. Organogenesis, a regenerative medicine company headquartered in Canton, Massachusetts, will perform the...
- This federal contract award was made by the Medical Supply Chain division of the U.S. Defense Department to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $5,100 fixed-price delivery order, awarded on May 12, 2025, is for PURAPLY AM XT 4.91x4.91 wound dressings with an ultimate completion date of May 15, 2025. The contract does not utilize a set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis holds...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
- This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,504.00 contract is for the supply of PURAPLY MICRONIZED, 500MG, a specialized medical product used for advanced wound care. The award has an ultimate completion date of July 21, 2025. Organogenesis is a for-profit manufacturer that holds several significant federal Indefinite Delivery Vehicles (IDVs)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
- This federal contract award, valued at $1,118.88, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is a delivery order for PURAPLY AM (2x2) 4 SQ CM, a wound care product. Organogenesis is a key supplier of medical products designed to support wound healing and tissue regeneration for military personnel and veterans. The company has established itself as a provider of...
- This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, to provide PURAPLY AM wound dressings to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,678.32 fixed-price with economic price adjustment delivery order has a period of performance through June 16, 2025. Organogenesis is an established supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies,...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment, with a completion date of March 20, 2025. The contract does not have a set-aside...
- This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine manufacturer based in Canton, Massachusetts. The contract is a delivery order for PURAPLY AM XT 4.91X4.91 wound dressings, which are used for advanced wound care. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and the DLA, including a $25 million...
- This is a $8,800.00 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a manufacturer of regenerative medicine products. The contract is for the delivery of PURAPLY AM XT wound care dressings and has a completion date of June 25, 2024. Organogenesis Inc. is a leading provider of advanced wound care and surgical biologics to the federal government, particularly the Department of Defense (DoD) and Department of Veterans...